Celgene’s Thalomid “Approvable” Again For Multiple Myeloma

FDA’s second approvable letter calls for labeling changes specific to an indication for newly diagnosed multiple myeloma.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet